Sunao Manabe
Chief Executive Officer chez DAIICHI SANKYO CO., LTD.
Postes actifs de Sunao Manabe
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DAIICHI SANKYO CO., LTD. | Chief Executive Officer | 01/06/2019 | - |
| Chairman | - | - | |
| Director/Board Member | 01/06/2014 | - | |
| Chief Operating Officer | 01/04/2017 | 01/06/2019 | |
| Human Resources Officer | 01/06/2016 | 01/04/2017 | |
| Corporate Officer/Principal | 01/04/2007 | 01/06/2016 | |
| President | 01/04/2017 | - | |
| Sales & Marketing | 01/04/2015 | 01/04/2016 | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Corporate Officer/Principal | 12/07/2023 | - |
Historique de carrière de Sunao Manabe
Statistiques
Internationale
| Suisse | 2 |
| Japon | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DAIICHI SANKYO CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |
- Bourse
- Insiders
- Sunao Manabe
- Expérience
